Fundraising Fox
/People
Sign in

Marco Prunotto

Investor

Venture Partner at Medicxi

Switzerland

Find your path to Marco

143 people in our graph can introduce you to Marco.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Francesco De Rubertis to introduce you to Marco

You →Francesco · together at Medicxi (2024–2026) →Marco

Ask Jamie Chen to introduce you to Marco

You →Jamie · 11 people · together at Medicxi →Marco

Sign up to find every way you can get introduced to Marco

  • Your email: the people you already email who know Marco
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Marco
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Marco Prunotto brings hands-on bench-to-bedside experience from leading Roche's phenotypic drug discovery, nephrology and translational research teams, while serving as Full Professor and teaching scientists VC evaluation of translational value.

Invests in

BiotechDigital HealthHealthtechMedical Devices

Experience

  1. MedicxiVenture Partnercurrent2024 — presentGenève, Suisse
  2. University of GenevaFull Professorcurrent2025 — present
  3. University of GenevaPrivat Docent (Senior Lecturer) - School of Pharmaceutical Sciences2018 — 2025Geneva Area, Switzerland
  4. RocheGlobal Head of Technology and Translational Research2021 — 2023Basel, Switzerland
  5. GalapagosHead of Translational Research2020 — 2021Basel, Basel-Town, Switzerland
  6. GenentechHead of I2O Innovation Office (Clinical Science Director)2018 — 2020Basel and San Francisco
  7. GenentechSenior Clinical Development Scientist2016 — 2018
  8. RochePhenotypic Drug Discovery & Target Identification Lead2013 — 2016Région de Basel, Suisse
  9. RocheRenal/Fibrosis Group lead (Principal Senior Scientist)2012 — 2013Région de Basel, Suisse
  10. RocheLaboratory Head (Principal Scientist)2010 — 2012Région de Basel, Suisse
  11. IRCCS Ospedale Pediatrico Giannina GasliniCell Biologist @ the Nephrology Department2008 — 2010Genoa Area, Italy
  12. University of GenevaPostdoctoral Fellow - - Pathology & Immunology Dept2004 — 2007Geneva Area, Switzerland

Skills & more

Artificial Intelligence (AI)2Artificial Neural Networks2Biology1Biochemistry16Biotechnology22Clinical Development12Cell17Drug Discovery49In Vitro36Life Sciences37In vitro8Molecular Biology15
+7 moreOncologyPharmaceutical IndustryPharmacologyCell BiologyCell CultureDrug DevelopmentImmunology

Languages English · French · German · Italian

From Marco's professional profile.

Colleagues at Medicxi

Andrew Jeanne
Investor at Medicxi
Ben Perry
Investor at Medicxi
Charles Grummitt
Investor at Medicxi
Charline Gesbert
Investor at Medicxi
Christopher Patton
Director at Medicxi
David Grainger
Investor at Medicxi
Florence Liaigre
Investor at Medicxi
Francesco De Rubertis
Investor at Medicxi

Frequently asked questions

Who is Marco Prunotto?
Marco Prunotto brings hands-on bench-to-bedside experience from leading Roche's phenotypic drug discovery, nephrology and translational research teams, while serving as Full Professor and teaching scientists VC evaluation of translational value.
Where does Marco Prunotto work?
Marco Prunotto is Venture Partner at Medicxi.
What does Marco Prunotto invest in?
Marco Prunotto invests in Biotech, Digital Health, Healthtech, Medical Devices.
Where did Marco Prunotto go to school?
Marco Prunotto studied at Università degli Studi di Torino (Doctor of Philosophy (PhD) - College of Veterinary Medicine, Basic Science and Applied Veterinary Biotechnology); Università degli Studi di Torino (Master of Biology (Botany), Biology - Botany).

Same school

Shared employers